Categories LATEST, Technology

Morgan Stanley just predicted the next trillion dollar company!

In an investor note on Wednesday, rating firm Morgan Stanley predicted the company it expects to hit the 13-digit market cap after Apple (AAPL). No surprises here – it’s Amazon (AMZN). Reiterating its overweight rating, Morgan Stanley raised the price target on the stock to $2,500 from $1,850, which would value the e-commerce giant at over $1.2 trillion.

With the latest rating announcement, Morgan Stanley has become Amazon’s biggest bull.

second trillion dollar company

According to analyst Brian Nowak, Amazon’s lucrative cloud service and rapid growth in advertising are expected to drive the company’s top-line further. He estimates profits from these two to hit about $25 billion this year and as much as $45 billion in the next two years.

Amazon shares were up 1.5% to 1,963.62 at 10:30 AM ET on Wednesday. The stock has rallied 65% so far this year, while the S&P 500 index is up just 8%.

In a separate note, the rating firm also raised the price target of Google parent Alphabet (GOOGL) to $1,515.

Also see: Why $1 trillion is just a pit stop for Apple

On August 2 this year at around 12 PM, Apple became the first trillion dollar US company, riding on a post-earnings rally, putting an end to months of speculations.

PetroChina, China’s second largest oil producer, is the first public company to breach the trillion dollar figure. The company touched the mark in November 2007 on Shanghai Stock Exchange, and in the following four months, tumbled to half its value.

Most Popular

Context Therapeutics: Another clinical-stage oncology research firm to go public soon

The US primary markets seem to be having a record-breaking start to the year, with over $171 billion raised in the first half of 2021 compared to $168 billion for

Biogen (BIIB) Stock: Does FDA nod for Aduhelm offer a buying opportunity?

The pharmaceutical industry has been witnessing hectic activity for some time, with most drug makers either channelizing their resources for vaccine development or engaging in COVID care programs. Biotechnology giant

IPO News: Monte Rosa Therapeutics will go public this week, here are a few things to know

Biotechnology company Monte Rosa Therapeutics is slated to go public this week. In a pandemic-ridden world, this industry is expanding at a healthy pace. The global biotechnology market is estimated

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top